518 First-in-human results with the novel tumor-targeting antibody ATRC-101: phase 1b study in patients with solid tumors
Regular and Young Investigator Award Abstracts | November 9, 2021 | Volume: No volume available | Issue: No issue available | Pages: A548-A548
10.1136/jitc-2021-sitc2021.518